JAGUAR HEALTH, INC. Operating Cash Flow
JAGUAR HEALTH, INC. (JAGX) reported Operating Cash Flow of $3.49 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-19.
Financial Statements › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2026-08-19
- JAGUAR HEALTH, INC. net cash provided by (used in) operating activities for the quarter ending 2026-06-30 was -$5.34M.
- JAGUAR HEALTH, INC. net cash provided by (used in) operating activities for the quarter ending 2026-03-31 was $8.83M.
- JAGUAR HEALTH, INC. net cash provided by (used in) operating activities for the quarter ending 2025-12-31 was -$5.49M.
- JAGUAR HEALTH, INC. net cash provided by (used in) operating activities for the quarter ending 2025-09-30 was -$4.69M.
- JAGUAR HEALTH, INC. net cash provided by (used in) operating activities for fiscal 2025 was -$23.69M.
- JAGUAR HEALTH, INC. net cash provided by (used in) operating activities for fiscal 2024 was -$29.38M.
- JAGUAR HEALTH, INC. net cash provided by (used in) operating activities for fiscal 2023 was -$33.24M.
- JAGUAR HEALTH, INC. net cash provided by (used in) operating activities for fiscal 2022 was -$33.10M.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 3 month as first filed | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 6 month as first filed | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 9 month as first filed | Net Cash Provided by (Used in) Operating Activities 12 month | Net Cash Provided by (Used in) Operating Activities 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$5.34M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-19 | $3.49M 10-Q · filed 2026-08-19 | -$2.00M derived: sum of 3 quarters · filed 2026-08-19 | -$6.68M derived: sum of 4 quarters · filed 2026-08-19 | ||||
| 2026-03-31 | $8.83M 10-Q · filed 2026-05-20 | $3.34M derived: sum of 2 quarters · filed 2026-05-20 | -$1.35M derived: sum of 3 quarters · filed 2026-05-20 | -$7.54M derived: sum of 4 quarters · filed 2026-08-19 | ||||
| 2025-12-31 | -$5.49M derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-07 | -$10.18M derived: sum of 2 quarters · filed 2026-04-07 | -$16.37M derived: sum of 3 quarters · filed 2026-08-19 | -$23.69M 10-K · filed 2026-04-07 | ||||
| 2025-09-30 | -$4.69M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | -$10.88M derived: sum of 2 quarters · filed 2026-08-19 | -$18.20M 10-Q · filed 2025-11-14 | -$26.02M derived: sum of 4 quarters · filed 2026-08-19 | ||||
| 2025-06-30 | -$6.20M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-19 | -$13.51M 10-Q · filed 2026-08-19 | -$21.34M derived: sum of 3 quarters · filed 2026-08-19 | -$27.68M derived: sum of 4 quarters · filed 2026-08-19 | ||||
| 2025-03-31 | -$7.31M 10-Q · filed 2026-05-20 | -$7.32M 10-Q · filed 2025-05-15 | -$15.14M derived: sum of 2 quarters · filed 2026-05-20 | -$21.48M derived: sum of 3 quarters · filed 2026-05-20 | -$29.65M derived: sum of 4 quarters · filed 2026-05-20 | |||
| 2024-12-31 | -$7.83M derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-07 | -$14.17M derived: sum of 2 quarters · filed 2026-04-07 | -$22.34M derived: sum of 3 quarters · filed 2026-04-07 | -$29.38M 10-K · filed 2026-04-07 | ||||
| 2024-09-30 | -$6.34M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | -$14.51M derived: sum of 2 quarters · filed 2025-11-14 | -$21.56M 10-Q · filed 2025-11-14 | -$29.01M derived: sum of 4 quarters · filed 2025-11-14 | ||||
| 2024-06-30 | -$8.17M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | -$15.22M 10-Q · filed 2025-08-14 | -$22.67M derived: sum of 3 quarters · filed 2025-08-14 | -$29.46M derived: sum of 4 quarters · filed 2025-08-14 | ||||
| 2024-03-31 | -$7.05M 10-Q · filed 2025-05-15 | -$14.50M derived: sum of 2 quarters · filed 2025-05-15 | -$21.29M derived: sum of 3 quarters · filed 2025-05-15 | -$30.34M derived: sum of 4 quarters · filed 2025-05-15 | ||||
| 2023-12-31 | -$7.45M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | -$14.24M derived: sum of 2 quarters · filed 2025-03-31 | -$23.30M derived: sum of 3 quarters · filed 2025-03-31 | -$33.24M 10-K · filed 2025-03-31 | ||||
| 2023-09-30 | -$6.79M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-13 | -$15.85M derived: sum of 2 quarters · filed 2024-11-13 | -$25.79M 10-Q · filed 2024-11-13 | -$32.21M derived: sum of 4 quarters · filed 2024-11-13 | ||||
| 2023-06-30 | -$9.06M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | -$19.00M 10-Q · filed 2024-08-13 | -$25.42M derived: sum of 3 quarters · filed 2024-08-13 | -$33.95M derived: sum of 4 quarters · filed 2024-08-13 | ||||
| 2023-03-31 | -$9.95M 10-Q · filed 2024-05-14 | -$16.37M derived: sum of 2 quarters · filed 2024-05-14 | -$24.90M derived: sum of 3 quarters · filed 2024-05-14 | -$35.35M derived: sum of 4 quarters · filed 2024-05-14 | ||||
| 2022-12-31 | -$6.42M derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | -$14.95M derived: sum of 2 quarters · filed 2024-04-01 | -$25.41M derived: sum of 3 quarters · filed 2024-04-01 | -$33.10M 10-K · filed 2024-04-01 | ||||
| 2022-09-30 | -$8.53M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | -$18.99M derived: sum of 2 quarters · filed 2023-11-14 | -$26.68M 10-Q · filed 2023-11-14 | -$35.60M derived: sum of 4 quarters · filed 2023-11-14 | ||||
| 2022-06-30 | -$10.46M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | -$18.15M 10-Q · filed 2023-08-14 | -$27.07M derived: sum of 3 quarters · filed 2023-08-14 | -$36.51M derived: sum of 4 quarters · filed 2023-08-14 | ||||
| 2022-03-31 | -$7.70M 10-Q · filed 2023-05-15 | -$16.62M derived: sum of 2 quarters · filed 2023-05-15 | -$26.05M derived: sum of 3 quarters · filed 2023-05-15 | -$35.96M derived: sum of 4 quarters · filed 2023-05-15 | ||||
| 2021-12-31 | -$8.92M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-24 | -$18.36M derived: sum of 2 quarters · filed 2023-03-24 | -$28.26M derived: sum of 3 quarters · filed 2023-03-24 | -$34.97M 10-K · filed 2023-03-24 | ||||
| 2021-09-30 | -$9.43M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | -$19.34M derived: sum of 2 quarters · filed 2022-11-14 | -$26.05M 10-Q · filed 2022-11-14 | -$30.11M derived: sum of 4 quarters · filed 2022-11-14 | ||||
| 2021-06-30 | -$9.91M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-22 | -$16.61M 10-Q · filed 2022-08-22 | -$20.68M derived: sum of 3 quarters · filed 2022-08-22 | -$23.59M derived: sum of 4 quarters · filed 2022-08-22 | ||||
| 2021-03-31 | -$6.71M 10-Q · filed 2022-05-10 | -$10.77M derived: sum of 2 quarters · filed 2022-05-10 | -$13.69M derived: sum of 3 quarters · filed 2022-05-10 | -$17.69M derived: sum of 4 quarters · filed 2022-05-10 | ||||
| 2020-12-31 | -$4.06M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-11 | -$6.98M derived: sum of 2 quarters · filed 2022-03-11 | -$10.98M derived: sum of 3 quarters · filed 2022-03-11 | -$15.28M 10-K · filed 2022-03-11 | ||||
| 2020-09-30 | -$2.92M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-17 | -$6.92M derived: sum of 2 quarters · filed 2021-11-17 | -$11.22M 10-Q · filed 2021-11-17 | -$14.36M derived: sum of 4 quarters · filed 2021-11-17 | ||||
| 2020-06-30 | -$4.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-13 | -$8.30M 10-Q · filed 2021-08-13 | -$11.44M derived: sum of 3 quarters · filed 2021-08-13 | -$19.98M derived: sum of 4 quarters · filed 2021-08-13 | ||||
| 2020-03-31 | -$4.30M 10-Q · filed 2021-05-17 | -$7.44M derived: sum of 2 quarters · filed 2021-05-17 | -$15.98M derived: sum of 3 quarters · filed 2021-05-17 | -$21.29M derived: sum of 4 quarters · filed 2021-05-17 | ||||
| 2019-12-31 | -$3.14M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-31 | -$11.69M derived: sum of 2 quarters · filed 2021-03-31 | -$16.99M derived: sum of 3 quarters · filed 2021-03-31 | -$20.46M 10-K · filed 2021-03-31 | -$20.46M 10-K · filed 2020-04-03 | |||
| 2019-09-30 | -$8.55M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-16 | -$13.85M derived: sum of 2 quarters · filed 2020-11-16 | -$17.32M 10-Q · filed 2020-11-16 | -$17.32M 10-Q · filed 2019-11-14 | -$22.22M derived: sum of 4 quarters · filed 2020-11-16 | |||
| 2019-06-30 | -$5.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-13 | -$8.77M 10-Q · filed 2020-08-13 | -$8.77M 10-Q · filed 2019-08-14 | -$13.67M derived: sum of 3 quarters · filed 2020-08-13 | -$16.48M derived: sum of 4 quarters · filed 2020-08-13 | |||
| 2019-03-31 | -$3.46M 10-Q · filed 2020-05-15 | -$3.47M 10-Q · filed 2019-05-21 | -$8.37M derived: sum of 2 quarters · filed 2020-05-15 | -$11.18M derived: sum of 3 quarters · filed 2020-05-15 | -$16.57M derived: sum of 4 quarters · filed 2020-05-15 | |||
| 2018-12-31 | -$4.90M derived: 10-K 12 month − 10-Q 9 month · filed 2020-04-03 | -$7.71M derived: sum of 2 quarters · filed 2020-04-03 | -$13.11M derived: sum of 3 quarters · filed 2020-04-03 | -$22.73M 10-K · filed 2020-04-03 | ||||
| 2018-09-30 | -$2.81M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-14 | -$8.21M derived: sum of 2 quarters · filed 2019-11-14 | -$17.83M 10-Q · filed 2019-11-14 | -$23.16M derived: sum of 4 quarters · filed 2019-11-14 | ||||
| 2018-06-30 | -$5.40M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-14 | -$15.02M 10-Q · filed 2019-08-14 | -$15.02M 10-Q · filed 2018-08-13 | -$20.35M derived: sum of 3 quarters · filed 2019-08-14 | -$23.38M derived: sum of 4 quarters · filed 2019-08-14 | |||
| 2018-03-31 | -$9.62M 10-Q · filed 2019-05-21 | -$14.95M derived: sum of 2 quarters · filed 2019-05-21 | -$17.98M derived: sum of 3 quarters · filed 2019-05-21 | -$19.16M derived: sum of 4 quarters · filed 2019-05-21 | ||||
| 2017-12-31 | -$5.33M derived: 10-K 12 month − 10-Q 9 month · filed 2019-04-10 | -$8.36M derived: sum of 2 quarters · filed 2019-04-10 | -$9.54M derived: sum of 3 quarters · filed 2019-04-10 | -$9.82M 10-K · filed 2019-04-10 | ||||
| 2017-09-30 | -$3.03M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-19 | -$4.21M derived: sum of 2 quarters · filed 2018-11-19 | -$4.49M 10-Q · filed 2018-11-19 | -$7.22M derived: sum of 4 quarters · filed 2018-11-19 | ||||
| 2017-06-30 | -$1.18M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-13 | -$1.47M 10-Q · filed 2018-08-13 | -$4.19M derived: sum of 3 quarters · filed 2018-08-13 | -$7.58M derived: sum of 4 quarters · filed 2018-08-13 | ||||
| 2017-03-31 | -$288.72K 10-Q · filed 2018-05-15 | -$3.02M derived: sum of 2 quarters · filed 2018-05-15 | -$6.40M derived: sum of 3 quarters · filed 2018-05-15 | |||||
| 2016-12-31 | -$2.73M derived: 10-K 12 month − 10-Q 9 month · filed 2018-04-09 | -$6.11M derived: sum of 2 quarters · filed 2018-04-09 | -$14.41M 10-K · filed 2018-04-09 | |||||
| 2016-09-30 | -$3.38M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-20 | -$11.69M 10-Q · filed 2017-11-20 | ||||||
| 2016-06-30 | -$8.30M 10-Q · filed 2017-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Latigo Biotherapeutics, Inc. (LTGO) | United States | $1.176B | |
| LB PHARMACEUTICALS INC (LBRX) | United States | $1.220B | -10.87 |
| OPKO HEALTH, INC. (OPK) | United States | $1.220B | -15.59 |
| Seaport Therapeutics, Inc. (SPTX) | United States | $1.131B | |
| HARROW, INC. (HROW) | United States | $1.240B | -42.77 |
| Damora Therapeutics, Inc. (DMRA) | $1.250B | -6.10 | |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |
| Avalyn Pharma Inc. (AVLN) | United States | $1.267B | |
| First Tracks Biotherapeutics, Inc. (TRAX) | United States | $1.280B | |
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |